This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
PRELIMINARY RESULTS OF A PHASE 2 TRIAL OF OBINUTUZUMAB, IN COMBINATION WITH IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (O-ICE) IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED/ REFRACTORY MATURE B-CELL NON-HODGKIN LYMPHOMA. (October 2022)
Record Type:
Journal Article
Title:
PRELIMINARY RESULTS OF A PHASE 2 TRIAL OF OBINUTUZUMAB, IN COMBINATION WITH IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (O-ICE) IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED/ REFRACTORY MATURE B-CELL NON-HODGKIN LYMPHOMA. (October 2022)
Main Title:
PRELIMINARY RESULTS OF A PHASE 2 TRIAL OF OBINUTUZUMAB, IN COMBINATION WITH IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE (O-ICE) IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED/ REFRACTORY MATURE B-CELL NON-HODGKIN LYMPHOMA